Farallon Capital Management »

Beta Bionics shares owned by Farallon Capital Management

Quarter-by-quarter ownership of Beta Bionics (BBNX) shares owned by Farallon Capital Management from 13F filings

Historical chart of Farallon Capital Management investment in Beta Bionics

Tip: Access up to 7 years of quarterly data

All positions including Beta Bionics held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beta Bionics by Farallon Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $86M 4.3M 19.87
2025-06-30 $61M 4.2M 14.56
2025-03-31 $41M 3.3M 12.24

More positions owned by Farallon Capital Management

Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Microsoft Corporation (MSFT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt Put Option (RSP)
Aon Shs Cl A (AON)
Exelixis (EXEL)
Amazon (AMZN)
Natera (NTRA)
Revolution Medicines (RVMD)
UnitedHealth (UNH)
Thermo Fisher Scientific (TMO)
Hims & Hers Health Com Cl A (HIMS)
Walt Disney Company (DIS)
salesforce (CRM)
Autodesk (ADSK)

View all positions for Farallon Capital Management

Top funds holding Beta Bionics

Eventide Asset Management
Farallon Capital Management
Wellington Management Company
Soleus Capital Management
Sands Capital Ventures
Rtw Investments
Morgan Stanley
BlackRock
Vanguard Group
Omega Fund Management
Deerfield Management Company
Driehaus Capital Management
Geode Capital Management
State Street Corporation
Millennium Management

View all funds holding Beta Bionics